Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
On March 19, 2018, Florida's Governor, Rick Scott, signed HB21. This legislation was proposed to combat the opioid epidemic in Florida.
Keep current with new legislation and its potential effect on your organization.
Keep current with new legislation and its potential effect on your organization.
The AASCIF Annual Conference brings together state funds from across the co